HCPCS Code Q0235
Injection, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, not otherwise classified, 1 mg
| Short Description | Inj, monoclon antibody, 1 mg |
|---|---|
| Year | 2026 |
| Coverage Code | C = Carrier judgment |
| Action Code | A = Add procedure or modifier code |
| Action Effective Date | October 01, 2025 |
| Code Added Date | October 01, 2025 |
| Pricing Indicator | 54 = Vaccinations |
| Type of Service | V = Pneumococcal/flu vaccine (eff 01/96), Pneumococcal/flu/hepatitis B vaccine (eff 04/95 - 12/95), Pneumococcal only before 04/95 |